We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAE.L Regulatory News (LSAE)

  • There is currently no data for LSAE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to the Specialist Fund Segment

26 Mar 2018 08:05

RNS Number : 8278I
Life Settlement Assets PLC
26 March 2018
 

 

Life Settlement Assets PLC

LEI: 2138003OL2VBXWG1BZ27

(the "Company" or "LSA") 

Admission to the Specialist Fund Segment

 

 

The directors of LSA are pleased to announce that the Company's entire issued share capital comprising 45,446,946 A Ordinary Shares of $0.01 each, 14,596,098 B Ordinary Shares of $0.01 each, 9,292,561 D Ordinary Shares of $0.01 each and 1,733,269 E Ordinary Shares of $0.01 each has been admitted to the Specialist Fund Segment of the London Stock Exchange ("Admission") at 8.00 a.m. today. Each Share carries the same voting rights (save in respect of matters relating solely to a specific Share Class), therefore the total number of voting rights in the Company is 71,068,874. Trading in the Predecessor Company's shares on the Luxembourg Stock Exchange was cancelled on 6 March 2018.

 

Shareholders should note that the obligations for shareholders to notify the Company of their shareholding apply at a lower threshold than was the case in Luxembourg. Under Chapter 5 of the Disclosure Guidance and Transparency Rules (the "DTRs"), subject to certain limited expectations, a person must notify the Company (and, at the same time, the FCA) of the percentage of voting rights he holds (within two trading days) if he acquires or disposes of Shares in the Company to which voting rights are attached and if, as a result of the acquisition or disposal, the percentage of voting rights which he holds as a Shareholder (or, in certain cases, which he holds indirectly) or through his direct or indirect holding of certain types of financial instruments (or a combination of such holdings):

 

(a) reaches, exceeds or falls below 3, 4, 5, 6, 7, 8, 9 or 10 per cent. and each 1 per cent threshold thereafter up to 100 per cent; or

(b) reaches, exceeds or falls below an applicable threshold in (a) above as a result of events changing the breakdown of voting rights and on the basis of the total voting rights notified to the market by the Company.

 

Such notification must be made using the prescribed form TR1 available from the FCA's website at http://www.fca.gov.uk. Under the DTRs, the Company must announce the notification to the public as soon as possible and in any event by not later than the end of the trading day following receipt of a notification in relation to voting rights."

 

The Company is a newly established closed-ended investment company whose principal activities are to support and manage portfolios of whole and partial interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company's investment objective is to generate long-term returns for investors by investing in the life settlement market.

 

Acheron Capital Limited ("Acheron") is responsible for devising and modelling the investment strategy of the Company's trusts. Founded in 2006 by Dr. Jean-Michel Paul, Acheron is a London based independent investment manager authorised and regulated by the Financial Conduct Authority that focuses on niche investment strategies uncorrelated to the traditional financial markets.

 

The Company believes that its admission to the Specialist Fund Segment provides it with the ideal platform to enhance the reputation, marketability, liquidity, and valuation of the Company's shares by gaining access to a wider investor audience.

 

The prospectus published by the Company on 30 January 2018 and the supplementary prospectus published by the Company on 23 March 2018 in connection with the Admission can be found on the Company's website www.lsaplc.com, and at the National Storage Mechanism at http://www.morningstar.co.uk/uk/NSM.

 

Save for expressions defined in this announcement, words and expressions defined in the Prospectus shall have the same meaning in this announcement.

 

For further information contact

 

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Stockdale Securities Limited (Financial Adviser and Broker)

Robert Finlay / Owen Matthews

020 7601 6115

 

TB Cardew (Financial PR)

Shan Shan Willenbrock

020 7930 0777

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDXLFLVXFBBBB
12
Date   Source Headline
4th May 20204:18 pmRNSCapital Reorganisation
29th Apr 20207:30 amRNSSuspension - Life Settlement Assets PLC
29th Apr 20207:00 amRNSResult of Meeting
27th Apr 20203:26 pmRNSAnnual Financial Report
2nd Apr 20207:00 amRNSPublication of circular and notice of GM
27th Mar 202012:59 pmRNSNet Asset Value(s)
23rd Mar 20209:55 amRNSDividend Declaration
16th Mar 20201:13 pmRNSNet Asset Value(s)
28th Feb 202011:13 amRNSNet Asset Value(s)
30th Jan 20207:00 amRNSCompany Update
10th Jan 20203:19 pmRNSHolding(s) in Company
3rd Jan 20209:55 amRNSNet Asset Value(s)
24th Dec 201911:36 amRNSHolding(s) in Company
18th Dec 20197:00 amRNSUpdate re share capital structure
13th Dec 20197:00 amRNSDirectorate Change
28th Nov 20197:00 amRNSNet Asset Value(s)
26th Nov 20195:45 pmRNSHolding(s) in Company
22nd Nov 20199:55 amRNSHolding(s) in Company
28th Oct 20197:00 amRNSNet Asset Value(s)
24th Oct 20193:21 pmRNSHolding(s) in Company
24th Oct 20197:00 amRNSDividend Declaration
1st Oct 201911:26 amRNSTotal Voting Rights
27th Sep 20197:00 amRNSNet Asset Value(s)
27th Sep 20197:00 amRNSDirectorate Change
27th Sep 20197:00 amRNSHalf-year Report
25th Sep 20197:00 amRNSNet Asset Value(s)
12th Sep 20197:00 amRNSTransaction in Own Shares
2nd Sep 20195:18 pmRNSTotal Voting Rights
23rd Aug 20197:00 amRNSTransaction in Own Shares
22nd Aug 20197:00 amRNSTransaction in Own Shares
21st Aug 20197:00 amRNSTransaction in Own Shares
20th Aug 20197:00 amRNSTransaction in Own Shares
19th Aug 20197:00 amRNSTransaction in Own Shares
16th Aug 20197:00 amRNSTransaction in Own Shares
15th Aug 20197:00 amRNSTransaction in Own Shares
14th Aug 20197:00 amRNSTransaction in Own Shares
13th Aug 20197:00 amRNSTransaction in Own Shares
6th Aug 20197:00 amRNSShare Buyback Programme
1st Aug 20194:21 pmRNSTotal Voting Rights
25th Jul 20197:00 amRNSNet Asset Value(s)
19th Jul 20193:23 pmRNSHolding(s) in Company
15th Jul 20199:27 amRNSDirector/PDMR Shareholding
10th Jul 20199:00 amRNSPolicy Maturities
5th Jul 20191:48 pmRNSDirector/PDMR Shareholding
3rd Jul 201912:21 pmRNSResults of Tender Offer and General/Class Meetings
24th Jun 20197:00 amRNSNet Asset Value(s)
20th Jun 20192:56 pmRNSShare Premium Account & Dividend Declaration
13th Jun 20195:31 pmRNSResult of AGM
6th Jun 20197:00 amRNSNet Asset Value(s)
4th Jun 201911:53 amRNSTender Offer
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.